SEVERE/VERY SEVERE COVID-19 ILLNESS

Clinical trials for SEVERE/VERY SEVERE COVID-19 ILLNESS explained in plain language.

Never miss a new study

Get alerted when new SEVERE/VERY SEVERE COVID-19 ILLNESS trials appear

Sign up with your email to follow new studies for SEVERE/VERY SEVERE COVID-19 ILLNESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Last-Chance drug access for serious illnesses

Disease control AVAILABLE

This program provides access to the drug ruxolitinib for patients with serious conditions like certain blood cancers and severe graft-versus-host disease. It is for people who have no other treatment options and cannot join a standard clinical trial. The program allows doctors to…

Matched conditions: SEVERE/VERY SEVERE COVID-19 ILLNESS

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

SEVERE/VERY SEVERE COVID-19 ILLNESS

Get alerted when new SEVERE/VERY SEVERE COVID-19 ILLNESS trials appear

Last-Chance drug access for serious illnesses